| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |